Does elective sclerotherapy improve the efficacy of long‐term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial
Olivier Ink, Thierry Martin, Thierry Poynard, Marc Reville, Marie‐Laure Anciaux, Claude Lenoir, Jean‐Luc Marill, Hélène Labadie, Claude Masliah, Daniel Perrin, Jean‐Claude Chaput, Denis Vetter, Claude Eugene, Louis Lebodic, Henri Licht, Jean‐Pierre Etienne – 1 October 1992 – We conducted a prospective, multicenter, randomized trial to compare the efficacy of sclerotherapy plus propranolol with that of propranolol alone in the prevention of recurrent gastroesophageal bleeding in severely cirrhotic patients.